Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Alzibit-D Tablet

Prescription Icon
Prescription Required

Marketer

Allenge India

Salt Composition

Diclofenac (50mg) + Trypsin Chymotrypsin (50000IU)

Overview Alzibit-D Tablet

Duralgin-DX tablets combine two active ingredients to alleviate pain and inflammation. This medication is indicated for conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis, and also provides relief from muscle aches, back pain, dental pain, and ear, nose, and throat discomfort. For optimal absorption and to minimize stomach upset, Duralgin-DX should be taken with food. Dosage is determined by the specific condition being treated and response to therapy, always following your physician's instructions. Exceeding the recommended dose or duration is strictly prohibited. Common side effects may include nausea, vomiting, dyspepsia, heartburn, abdominal pain, anorexia, and diarrhea. Report any persistent or worsening side effects to your doctor, who may offer strategies for mitigation. Prior to commencing treatment, disclose any history of peptic ulcers, gastrointestinal bleeding, hypertension, or pre-existing cardiac, renal, or hepatic impairment. Complete disclosure of all other medications is crucial, as interactions may occur. Pregnant or lactating individuals should seek medical advice before using this medication. Concurrent alcohol consumption should be avoided due to the risk of increased drowsiness.

Uses of Alzibit-D Tablet

Analgesia

Major Benefits of Alzibit-D Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Consume Alzibit-D Tablet with a meal.

Common Side effects of Alzibit-D Tablet:

  • Nausea
  • Vomiting
  • Indigestion
  • Stomach pain
  • Loss of appetite
  • Diarrhea

How to use Alzibit-D Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or fracture it. Alzibit-D Tablets should be administered with food.

How Alzibit-D Tablet works:

Alzibit-D tablets combine diclofenac and trypsin-chymotrypsin to alleviate pain and inflammation. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of pain, fever, and inflammation-causing compounds within the body. The trypsin-chymotrypsin enzyme blend degrades proteins, facilitating their absorption into the bloodstream. This enhanced absorption improves circulation at the site of inflammation, thus diminishing swelling.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Alzibit-D tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Alzibit-D tablets during pregnancy poses a confirmed risk to the fetus. Prescribing it is generally avoided, except in rare, life-threatening circumstances where the potential benefits clearly outweigh the dangers. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Alzibit-D Tablet use while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Driving ability may be impaired by Alzibit-D Tablet side effects. Some individuals taking Alzibit-D Tablet experience headaches, blurred vision, dizziness, or drowsiness; these symptoms can impact driving capabilities.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Alzibit-D Tablets; dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Alzibit-D tablets, potentially requiring dosage modification. Physician consultation is advised. For extended use in such patients, routine liver function assessments are recommended.

What if you forget to take Alzibit-D Tablet :

Should you forget to take your Alzibit-D Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Alzibit-D Tablet

LabelValue
Addictive None.
Type of Medication Pain relievers

FAQs on Alzibit-D Tablet

Exceeding the prescribed dosage won't necessarily enhance treatment; instead, it heightens the risk of severe adverse reactions and potential poisoning. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Patients with hypersensitivity to Alzibit-D Tablet constituents or inactive ingredients should not take this medication. Individuals with a history of peptic ulcers or experiencing active, recurring stomach ulcers/bleeding should generally refrain from using this drug. Similarly, its use is contraindicated in those with a history of congestive heart failure, hypertension, or hepatic or renal impairment.
Alzibit-D Tablets have an expiration date. Confirm the expiration date printed on the product packaging. Discard Alzibit-D Tablets once the expiration date has passed.
Alzibit-D tablets contain diclofenac, trypsin, and chymotrypsin, working synergistically to reduce pain and inflammation. The formulation diminishes the concentration of inflammatory mediators responsible for these symptoms.
Alzibit-D Tablet has not been reported to cause addiction in any patients.
Alzibit-D tablets are typically prescribed for short-term use and may be stopped once pain subsides. Nevertheless, continued use should follow your physician's recommendations.
Indeed, Alzibit-D Tablet may induce dizziness in certain individuals, manifesting as faintness, weakness, unsteadiness, or lightheadedness. Should you experience such symptoms, cease your current activity and rest in a seated or reclining position until the sensation subsides. Refrain from operating vehicles or machinery during this time.
Chronic Alzibit-D Tablet consumption may impair kidney function. Healthy kidneys naturally generate prostaglandins, chemicals that offer protective benefits. Pain relievers decrease prostaglandin production, increasing the risk of kidney damage with prolonged use. Individuals with pre-existing kidney conditions should avoid taking pain medication.
The onset of pain relief from Alzibit-D Tablet may be observed within approximately sixty minutes.
Should you miss a dose of Alzibit-D Tablet, and your next dose is nearly due, omit the missed dose and continue with your regular schedule. If your next dose is not imminent, take the missed dose immediately upon remembering, then resume your usual dosing pattern. Avoid doubling up on doses to compensate for a missed one, as this might heighten the chance of adverse reactions from an overdose. When uncertain about the proper course of action, seek guidance from your physician.
Alzibit-D Tablet
70
MRP 85
17% off